Skeletal muscle capillarity during hypoxia: VEGF and its activation

High Altitude Medicine and Biology

Volumn 9, Issue 2, 2008, Pages 158-166

  Breen, Ellen ^a,b   Tang, Kechun ^a   Olfert, Mark ^a   Knapp, Amy ^a   Wagner, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Exercise; Extreme altitude; Hypoxic ventilatory response; Muscle capillarity; Muscle fibers; Oxygen delivery

Indexed keywords

ADENOSINE; ADENYLATE KINASE; CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ALTITUDE; ANGIOGENESIS; CAPILLARY DENSITY; EXERCISE; FEEDBACK SYSTEM; GENE DELETION; HUMAN; HYPOXIA; INFLAMMATION; LONG TERM EXPOSURE; MOUNTAINEERING; NONHUMAN; OXIDATIVE STRESS; OXYGEN TRANSPORT; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SKELETAL MUSCLE; TRANSCRIPTION INITIATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANOXIA; CAPILLARIES; ENDOTHELIAL GROWTH FACTORS; HUMANS; MAMMALS; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; REGIONAL BLOOD FLOW; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 46249099279     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2008.1010     Document Type: Review

References (76)

1. Adair T.H. (2005). Growth regulation of the vascular system: an emerging role for adenosine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289:R283-R296.
2. Adair T.H., Gay W.J., and Montani J.P (1990). Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am. J. Physiol. 259:R393-R404.
3. Aravindan N., Aravindan S., Shanmugasundaram K., and Shaw A.D. (2007). Periods of systemic partial hypoxia induces apoptosis and inflammation in rat skeletal muscle. Mol. Cell. Biochem. 302:51-58.
4. Banchero N. (1987). Cardiovascular responses to chronic hypoxia. Annu. Rev. Physiol. 49:465-476.
5. Bigard A.X., Brunet A., Guezennec C.Y., and Monod H. (1991). Effects of chronic hypoxia and endurance training on muscle capillarity in rats. Pflugers Arch. 419:225-229.
6. Breen E.C., Johnson E.C., Wagner H., Tseng H.M., Sung L.A., and Wagner P.D. (1996). Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J. Appl. Physiol. 81:355-361.
7. Brown M.D., and Hudlicka O. (2003). Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases. Angiogenesis. 6:1-14.
8. Chang D.S., Su H., Tang G.L., Brevetti L.S., Sarkar R., Wang R., Kan Y.W., and Messina L.M. (2003). Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb. Mol. Ther. 7:44-51.
9. Chen C., Pore N., Behrooz A., Ismail-Beigi F., and Maity A. (2001). Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J. Biol. Chem. 276:9519-9525.
10. Clanton T.L. (2007). Hypoxia-induced reactive oxygen species formation in skeletal muscle. J. Appl. Physiol. 102:2379-2388.
11. Clark A.N., Youkey R., Liu X., Jia L., Blatt R., Day Y.J., Sullivan G.W., Linden J., and Tucker A.L. (2007). A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Circ. Res. 101:1130-1138.
12. Cohen T., Nahari D., Cerem L.W., Neufeld G., and Levi B.Z. (1996). Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271:736-741.
13. Deveci D., Marshall J.M., and Egginton S. (2001). Relationship between capillary angiogenesis, fiber type, and fiber size in chronic systemic hypoxia. Am. J. Physiol. Heart Circ. Physiol. 281:H241-H252.
14. Deveci D., Marshall J.M., and Egginton S. (2002). Chronic hypoxia induces prolonged angiogenesis in skeletal muscles of rat. Exp. Physiol. 87:287-291.
15. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1029-1039.
16. Fandrey J. (2004). Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286:R977-R988.
17. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., and Moore M.W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:439-442.
18. Ferrara N., Gerber H.P., and LeCouter J. (2003). The biology of VEGF and its receptors. Nat. Med. 9:669-676.
19. Forsythe J., Jiang B., Iyer N., Agani F., Leung S., Koos R., and Semenza G. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-4613.
20. Fujino H., Kohzuki H., Takeda I., Kiyooka T., Miyasaka T., Mohri S., Shimizu J., and Kajiya F. (2005). Regression of capillary network in atrophied soleus muscle induced by hindlimb unweighting. J. Appl. Physiol. 98:1407-1413.
21. Gerber H.P., McMurtrey A., Kowalski J., Yan M., Keyt B.A., Dixit V., and Ferrara N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273:30336-30343.
22. Green H.J., Sutton J.R., Cymerman A., Young P.M., and Houston C.S. (1989). Operation Everest II: adaptations in human skeletal muscle. J. Appl. Physiol. 66:2454-2461.
23. Grishko V., Solomon M., Breit J.F., Killilea D.W., Ledoux S.P., Wilson G.L., and Gillespie M.N. (2001). Hypoxia promotes oxidative base modifications in the pulmonary artery endothelial cell VEGF gene. FASEB J. 15:1267-1269.
24. Gu J.W., Ito B.R., Sartin A., Frascogna N., Moore M., and Adair T.H. (2000). Inhibition of adenosine kinase induces expression of VEGF mRNA and protein in myocardial myoblasts. Am. J. Physiol. Heart Circ. Physiol. 279:H2116-H2123.
25. Hardie D.G., Hawley S.A., and Scott J.W. (2006). AMP-activated protein kinase - development of the energy sensor concept. J. Physiol. 574:7-15.
26. Hartmann G., Tschop M., Fischer R., Bidlingmaier C., Riepl R., Tschop K., Hautmann H., Endres S., and Toepfer M. (2000). High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine. 12:246-252.
27. Harvey T.C., James H.M., and Chettle D.R. (1979). Birmingham Medical Research Expeditionary Society 1977 Expedition: effect of a Himalayan trek on whole body composition, nitrogen and potassium. Postgrad. Med. J. 55:475-477.
28. Hellwig-Burgel T., Rutkowski K., Metzen E., Fandrey J., and Jelkmann W. (1999). Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94:1561-1567.
29. Hoppeler H., Howald H., and Cerretelli P (1990a). Human muscle structure after exposure to extreme altitude. Experientia. 46:1185-1187.
30. Hoppeler H., Kleinert E., Schlegel C., Claassen H., Howald H., Kayar S.R., and Cerretelli P. (1990b). Morphological adaptations of human skeletal muscle to chronic hypoxia. Int. J. Sports Med. 11 Suppl. 1:S3-S9.
31. Huang L.E., Arany Z., Livingston D.M., and Bunn H.F. (1996). Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271:32253-32259.
32. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., and Poellinger L. (1999). Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274:6519-6525.
33. Kamba T., Tam B.Y., Hashizume H., Haskell A., Sennino B., Mancuso M.R., Norberg S.M., O'Brien S.M., Davis R.B., Gowen L.C., Anderson K.D., Thurston G., Joho S., Springer M.L., Kuo C.J., and McDonald D.M. (2006). VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am. J. Physiol. Heart Circ. Physiol. 290:H560-H576.
34. Kosmidou I., Xagorari A., Roussos C., and Papapetropoulos A. (2001). Reactive oxygen species stimulate VEGF production from C(2)C(12) skeletal myotubes through a PI3K/Akt pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L585-L592.
35. Kubo K., Hanaoka M., Hayano T., Miyahara T., Hachiya T., Hayasaka M., Koizumi T., Fujimoto K., Kobayashi T., and Honda T. (1998). Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high-altitude pulmonary edema. Respir. Physiol. 111:301-310.
36. Kuzmin A.I., Lakomkin V.L., Kapelko V.I., and Vassort G. (1998). Interstitial ATP level and degradation in control and post-myocardial infarcted rats. Am. J. Physiol. 275:C766-C771.
37. Levy A.P., Levy N.S., Wegner S., and Goldberg M.A. (1995). Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270:13333-13340.
38. Levy A.P., Levy N.S., and Goldberg M.A. (1996). Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271:2746-2753.
39. Liu Y., Cox S.R., Morita T., and Kourembanas S. (1995). Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77:638-643.
40. Luptak I.., Shen M., He H., Hirshman M.F., Musi N., Goodyear L.J., Yan J., Wakimoto H., Morita H., Arad M., Seidman C.E., Seidman J.G., Ingwall J.S., Balschi J.A., and Tian R. (2007). Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage. J. Clin. Invest. 117:1432-1439.
41. MacDougall J.D., Green H.J., Sutton J.R., Coates G., Cymerman A., Young P., and Houston C.S. (1991). Operation Everest II: structural adaptations in skeletal muscle in response to extreme simulated altitude. Acta Physiol. Scand. 142:421-427.
42. Marti H.J., Bernaudin M., Bellail A., Schoch H., Euler M., Petit E., and Risau W. (2000). Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol. 156:965-976.
43. Mason S.D., Howlett R.A., Kim M.J., Olfert I.M., Hogan M.C., McNulty W., Hickey R.P., Wagner P.D., Kahn C.R., Giordano F.J., and Johnson R.S. (2004). Loss of skeletal muscle HIF-1alpha results in altered exercise endurance. PLoS Biol. 2:E288.
44. Milkiewicz M., Hudlicka O., Shiner R., Egginton S., and Brown M.D. (2006). Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat. J. Physiol. 577:671-678.
45. Moreau C., Devos D., Brunaud-Danel V., Defebvre L., Perez T., Destee A., Tonnel A.B., Lassalle P., and Just N. (2005). Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? Neurology. 65:1958-1960.
46. Nagata D., Mogi M., and Walsh K. (2003). AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J. Biol. Chem. 278:31000-31006.
47. Olfert I.M., Breen E.C., Mathieu-Costello O., and Wagner P.D. (2001a). Chronic hypoxia attenuates resting and exercise-induced VEGF, flt-1, and flk-1 mRNA levels in skeletal muscle. J. Appl. Physiol. 90:1532-1538.
48. Olfert I.M., Breen E.C., Mathieu-Costello O., and Wagner P.D. (2001b). Skeletal muscle capillarity and angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia. J. Appl. Physiol. 91:1176-1184.
49. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., and Carmeliet P. (2001). Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genetics 28:131-138.
50. Orth T.A., Allen J.A., Wood J.G., and Gonzalez N.C. (2005). Exercise training prevents the inflammatory response to hypoxia in cremaster venules. J. Appl. Physiol. 98:2113-2118.
51. Ouchi N., Shibata R., and Walsh K. (2005). AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ. Res. 96:838-846.
52. Page E.L., Robitaille G.A., Pouyssegur J., and Richard D.E. (2002). Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem. 277:48403-48409.
53. Poole D.C., and Mathieu-Costello O. (1989). Skeletal muscle capillary geometry: adaptation to chronic hypoxia. Respir. Physiol. 77:21-29.
54. Pucar D., Dzeja P.P., Bast P., Gumina R.J., Drahl C., Lim L., Juranic N., Macura S., and Terzic A. (2004). Mapping hypoxiainduced bioenergetic rearrangements and metabolic signaling by 18O-assisted 31P NMR and 1H NMR spectroscopy. Mol. Cell. Biochem. 256-257:281-289.
55. Ramanathan M., Giladi A., and Leibovich S.J. (2003). Regulation of vascular endothelial growth factor gene expression in murine macrophages by nitric oxide and hypoxia. Exp. Biol. Med. (Maywood) 228:697-705.
56. Reznick R.M., Zong H., Li J., Morino K., Moore I.K., Yu H.J., Liu Z.X., Dong J., Mustard K.J., Hawley S.A., Befroy D., Pypaert M., Hardie D.G., Young L.H., and Shulman G.I. (2007). Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell. Metab. 5:151-156.
57. Richardson R.S., Wagner H., Mudaliar S.R., Henry R., Noyszewski E.A., and Wagner P.D. (1999). Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am. J. Physiol. 277:H2247-H2252.
58. Robach P., Cairo G., Gelfi C., Bernuzzi F., Pilegaard H., Vigano A., Santambrogio P., Cerretelli P., Calbet J.A., Moutereau S., and Lundby C. (2007). Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle. Blood. 109:4724-4731.
59. Rockl K.S., Hirshman M.F., Brandauer J., Fujii N., Witters L.A., and Goodyear L.J. (2007). Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes. 56:2062-2069.
60. Rose M.S., Houston C.S., Fulco C.S., Coates G., Sutton J.R., and Cymerman A. (1988). Operation Everest. II: nutrition and body composition. J. Appl. Physiol. 65:2545-2551.
61. Ryuto M., Ono M., Izumi H., Yoshida S., Weich H.A., Kohno K., and Kuwano M. (1996). Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J. Biol. Chem. 271:28220-28228.
62. Schafer G., Cramer T., Suske G., Kemmner W., Wiedenmann B., and Hocker M. (2003). Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J. Biol. Chem. 278:8190-8198.
63. Semenza G.L., Roth P.H., Fang H.M., and Wang G.L. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:23757-23763.
64. Shah S., Allen J., Wood J.G., and Gonzalez N.C. (2003). Dissociation between skeletal muscle microvascular PO2 and hypoxiainduced microvascular inflammation. J. Appl. Physiol. 94:2323-2329.
65. Shima D.T., Kuroki M., Deutsch U., Ng Y.S., Adamis A.P., and D'Amore P.A. (1996). The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271:3877-3883.
66. Snyder G.K., Wilcox E.E., and Burnham E.W. (1985). Effects of hypoxia on muscle capillarity in rats. Respir. Physiol. 62:135-140.
67. Stein I., Itin A., Einat P., Skaliter R., Grossman Z., and Keshet E. (1998). Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol. Cell. Biol 18:3112-3119.
68. Steiner D.R., Gonzalez N.C., and Wood J.G. (2003). Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J. Appl. Physiol. 94:325-334.
69. Stroka D.M., Burkhardt T., Desbaillets I., Wenger R.H., Neil D.A., Bauer C., Gassmann M., and Candinas D. (2001). HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J. 15:2445-2453.
70. Tanaka T., Kanai H., Sekiguchi K., Aihara Y., Yokoyama T., Arai M., Kanda T., Nagai R., and Kurabayashi M. (2000). Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J. Mol. Cell. Cardiol. 32:1955-1967.
71. Tang K., Breen E.C., Gerber H.P., Ferrara N.M., and Wagner P.D. (2004). Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol. Genomics 18:63-69.
72. Tsai A.G., Cabrales P., Winslow R.M., and Intaglietta M. (2003). Microvascular oxygen distribution in awake hamster window chamber model during hyperoxia. Am. J. Physiol. Heart Circ. Physiol. 285:H1537-H1545.
73. Tuomisto T.T., Rissanen T.T., Vajanto I., Korkeela A., Rutanen J., and Yla-Herttuala S. (2004). HIF-VEGF-VEGFR-2, TNF-alpha and IGF pathways are upregulated in critical human skeletal muscle ischemia as studied with DNA array. Atherosclerosis. 174:111-120.
74. Tzima E., Irani-Tehrani M., Kiosses W.B., Dejana E., Schultz D.A., Engelhardt B., Cao G., DeLisser H., and Schwartz M.A. (2005). A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature. 437:426-431.
75. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X.F., and Achong M.K. (1998). IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101:311-320.
76. Zuo L., and Clanton T.L. (2005). Reactive oxygen species formation in the transition to hypoxia in skeletal muscle. Am. J. Physiol. Cell. Physiol. 289:C207-C216.